Desvenlafaxine NDC 71335-2512

Product information

Brand name (proprietary)

Desvenlafaxine

Generic name (nonproprietary)

desvenlafaxine

Active ingredients

Desvenlafaxine succinate — 100 mg/1

Dosage form

Tablet, Extended release

Route

Oral

Labeler

Bryant Ranch Prepack

Product type

Prescription drug

Marketing category

ANDA — Abbreviated New Drug Application (generic)Application ANDA 204028

Marketing start

Jan 31, 2022

Listing expires

Dec 31, 2027

Other FDA classes

Cytochrome P450 2D6 Inhibitors (Mechanism)Norepinephrine Uptake Inhibitors (Mechanism)Serotonin Uptake Inhibitors (Mechanism)

Identifiers

Product ID 71335-2512_a87becdb-b5d0-4c1f-8016-07c64969e3b0SPL ID a87becdb-b5d0-4c1f-8016-07c64969e3b0SPL set ID 643bfe62-7885-4db4-9fff-5d8552b53d14RxCUI 1874553UNII ZB22ENF0XR

Pharmacologic class

Serotonin and Norepinephrine Reuptake Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N471335251201 followed by a unit qualifier and the quantity Copy

Package 71335-2512-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Other NDCs under ANDA 204028

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.